Be part of the knowledge.™

NeuroFrontiers

Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.

So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.

371

LikeLikedUnlike

Episodes 1-15 of 337

Advancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
NeuroFrontiers
Advancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Ragy R. Girgis, MD, MS
  Peer
- Desiree Matthews, PMHNP-BC
  Peer
Using fMRI to Identify Early Alzheimer’s Disease Subgroups
NeuroFrontiers
Using fMRI to Identify Early Alzheimer’s Disease Subgroups
- Hamid Abuwarda, PhD, BS
  Peer
Evaluating AR1001: A Phase 3 Trial in Early Alzheimer’s Disease
NeuroFrontiers
Evaluating AR1001: A Phase 3 Trial in Early Alzheimer’s Disease
- Sharon Sha, MD, MS
  Peer
Understanding Schizophrenia: The Role of Neurotransmission and Inflammation
NeuroFrontiers
Understanding Schizophrenia: The Role of Neurotransmission and Inflammation
- Jeffrey A. Lieberman, MD
  Peer
Harnessing AI to Predict and Prevent Schizophrenia Relapse
NeuroFrontiers
Harnessing AI to Predict and Prevent Schizophrenia Relapse
- Matcheri S. Keshavan, MD
  Peer
Engaging Patients and Caregivers in Schizophrenia: A Collaborative Care Approach
NeuroFrontiers
Engaging Patients and Caregivers in Schizophrenia: A Collaborative Care Approach
- Shelina Ramnarine, PhD
  Peer
- Apurva Bhatt, MD
  Peer
- Shannon Pagdon, BA
  Peer
advertisement
Applying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
NeuroFrontiers
Applying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- David Kimhy, PhD
  Peer
Advancing gMG Care: Conversations with Clinicians at AANEM
NeuroFrontiers
Advancing gMG Care: Conversations with Clinicians at AANEM
- Marlene Mimi Maeusli, PhD
  Peer
- Michael Weiss, MD
  Peer
- Joshua Alpers, MD
  Peer
- James F. Howard, Jr, MD
  Peer
- Omar Sinno, MD, MBA
  Peer
- Rodrigo Rodriguez, MD
  Peer
- Sheetal Shroff, MD
  Peer
Personalizing Treatment for gMG: On the Ground at AANEM
NeuroFrontiers
Personalizing Treatment for gMG: On the Ground at AANEM
- Marlene Mimi Maeusli, PhD.
  Peer
- Rodrigo Rodriguez, MD
  Peer
- Sheetal Shroff, MD
  Peer
- Joshua Alpers, MD
  Peer
Evaluating Sabirnetug in Early Alzheimer’s: Targeting Soluble Aβ Oligomers
NeuroFrontiers
Evaluating Sabirnetug in Early Alzheimer’s: Targeting Soluble Aβ Oligomers
Individualized Cognitive Stimulation in Mild Alzheimer’s Disease: Evidence from a Multicenter RCT
NeuroFrontiers
Individualized Cognitive Stimulation in Mild Alzheimer’s Disease: Evidence from a Multicenter RCT
Aducanumab in Early Alzheimer's: Slowing Cognitive and Functional Decline
NeuroFrontiers
Aducanumab in Early Alzheimer's: Slowing Cognitive and Functional Decline
- Ryan Quigley
  Peer
advertisement
Optimizing Generalized Myasthenia Gravis Care Through Patient-Centered Choices
NeuroFrontiers
Optimizing Generalized Myasthenia Gravis Care Through Patient-Centered Choices
- Sheetal Shroff, MD
  Peer
Timing Meningococcal Vaccines in gMG: Challenges and Considerations
NeuroFrontiers
Timing Meningococcal Vaccines in gMG: Challenges and Considerations
- Michael Weiss, MD
  Peer
Individualizing gMG Treatment: Defining Success With Each Patient
NeuroFrontiers
Individualizing gMG Treatment: Defining Success With Each Patient
- Omar Sinno, MD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended